AstraZeneca to build US$1.5 bln cancer drug facility in Singapore


SINGAPORE (May 21): British pharmaceutical giant AstraZeneca said Monday that it planned to build a US$1.5 billion (RM4.687 billion) plant in Singapore to manufacture next-generation drugs to treat cancer. The facility, to be ready by 2029, will produce antibody-drug conjugates (ADCs), a promising type of treatment that attacks cancer cells without damaging the surrounding healthy ones, [...]

Read more at : theborneopost

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.